MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Memorial Sloan Kettering Cancer Center (MSK)

Status: Enrolling

Conditions: Breast Cancer; Prostate Cancer

Treatments: Other: Experimental: Enhanced Telehealth (ET); Other: Usual practice pattern (UPP)

Study type: Interventional

Funder types: Other

Identifiers

NCT06954337

25-055

Details and patient eligibility

About

Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.

Enrollment: 1,750 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with breast or prostate cancer at Memorial Sloan Kettering Cancer Center who have had at least 3 prior medical oncology visits.

Exclusion criteria

• Patient is enrolled on a therapeutic clinical trial.
• Patients whose primary language is not currently supported by Epic.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

1,750 participants in 2 patient groups

Usual practice pattern (UPP)

Active Comparator group

Description:

Usual practice pattern (UPP) of patient's medical oncologist

Treatment:

Other: Experimental: Enhanced Telehealth (ET)

Other: Usual practice pattern (UPP)

Enhanced Telehealth (ET)

Experimental group

Description:

Enhanced Telehealth (ET) practice pattern of patient's medical oncologist

Treatment:

Other: Experimental: Enhanced Telehealth (ET)

Other: Usual practice pattern (UPP)